Diabetic Nephropathy, also referred to as Diabetic Kidney Disease, is a progressive kidney condition that damages the capillaries in the kidneys’ glomeruli. It is a common complication of diabetes and one of the leading causes of chronic kidney disease in the western world. This ailment is characterized by progressive decline in the glomerular filtration rate, elevated arterial blood pressure, and persistent albuminuria. Early treatment is crucial to preventing or delaying the onset of diabetic nephropathy. The global diabetic nephropathy market is projected to grow at a CAGR of 6% from 2013 to 2018 (forecast period). This is credited to rising incidences of obesity and diabetes across the globe. Reputed industry players are making huge investments in the research & development of drugs for treating diabetic nephropathy. Moreover, awareness of patients regarding diabetes and kidney-related problems is also on the rise. These factors will have a favorable impact on market growth. However, stringent regulatory procedures, a time-consuming drug-approval process, and poor therapeutic management of diabetic nephropathy may restrict industry expansion. Controlling blood pressure and blood glucose levels limits kidney damage. There are various treatment options for diabetic nephropathy. Disease modifying therapies is the largest and most popular method of treatment. Chief sub-segments of disease modifying therapies encompass diuretics, antioxidant inflammation modulator, rennin inhibitors, angiotensin II receptor blockers (ARBs), calcium channel blockers, monocyte chemo attractants proteins inhibitor, angiotensin-converting enzyme (ACE) inhibitors, and connective tissue growth factor inhibitors. ACE inhibitors are anticipated to grow at the fastest rate over the forecast period. North America, Europe, Asia Pacific, and RoW (Rest of the World) are the main geographical markets. Asia Pacific is projected to witness lucrative growth owing to rising incidences of diabetes mellitus amongst its populace. India and China are estimated to account for a majority of the total diabetics in the coming years. India has been declared the ‘Diabetes Capital’ of the world. North America is another key regional market. Various governments in this region are spreading awareness of diabetes and related kidney disorders. The diabetic nephropathy industry in Europe will benefit from rising expenditure on treatment of diabetes. Key players in the global diabetic nephropathy market are Novartis International AG, Sanofi S.A., Abbott Laboratories, Merck & Co. Inc., and Pfizer Inc.
Table of Contents 1. Executive Summary 2. List of Abbreviations 3. Scope of the Report 3.1 Market Overview 3.2 Product Offerings Product Profiles 4. Market Research Methodology 4.1 Market Research Process 4.2 Research Methodology 5. Introduction 6. Market Landscape 6.1 Market Overview 6.2 Market Size and Forecast 6.3 DN Market in the US 6.3.1 Market Size and Forecast 6.4 DN Market in Europe 6.4.1 Market Size and Forecast 6.5 Five Forces Analysis 7. Pipeline Snapshot 8. Rate of Incidence and Prevalence 9. Geographical Segmentation 9.1 DN Market in the Americas 9.1.1 Market Size and Forecast 9.2 DN Market in the EMEA Region 9.2.1 Market Size and Forecast 9.3 DN Market in the APAC Region 9.3.1 Market Size and Forecast 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 17.1 Competitive Scenario 17.1.1 Key News 17.1.2 Mergers and Acquisitions 17.2 Market Share Analysis 2013 17.3 Other Prominent Vendors 18. Key Vendor Analysis 18.1 Merck & Co. Inc. 18.1.1 Business Overview 18.1.2 Business Segmentation 18.1.3 Key Information 18.1.4 SWOT Analysis 18.2 Mitsubishi Tanabe Pharma Corp. 18.2.1 Business Overview 18.2.2 Key Information 18.2.3 SWOT Analysis 18.3 Novartis AG 18.3.1 Business Overview 18.3.2 Business Segmentation 18.3.3 Key Information 18.3.4 SWOT Analysis 18.4 Sanofi S.A. 18.4.1 Business Overview 18.4.2 Business Segmentation 18.4.3 Key Information 18.4.4 SWOT Analysis 19. Other Reports in this Series List of Exhibits: Exhibit 1: Market Research Methodology Exhibit 2: Global DN Market 2013-2018 (US$ billion) Exhibit 3: DN Market in the US 2013-2018 (US$ billion) Exhibit 4: DN Market in Europe 2013-2018 (US$ billion) Exhibit 5: Global DN Market by Geographical Segmentation 2013 Exhibit 6: DN Market in the Americas 2013-2018 (US$ billion) Exhibit 7: DN Market in the EMEA Region 2013-2018 (US$ billion) Exhibit 8: DN Market in the APAC Region (US$ billion) Exhibit 9: Global DN Market by Geographical Segmentation Exhibit 10: Business Segmentation of Merck & Co. Inc. Exhibit 11: Business Segmentation of Novartis AG Exhibit 12: Business Segmentation of Sanofi S.A.
Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the glRead More...October 13, 2015
Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demandRead More...October 6, 2015
Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commercRead More...October 12, 2015
Global Aerial Work Platform (AWP) truck market is expected to be valued at USD 8,003.7 million by 2022, as per a new research report by Radiant Insights, Inc. Rapid infrastructure growth due to rising real estate investment is expected to drive the iRead More...October 14, 2015
Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanomRead More...October 6, 2015
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.